Rhenman & Partners Asset Management Ab Portfolio Holdings

Rhenman & Partners Asset Management Ab

  • $766 Million
  • Q2 2025

Rhenman & Partners Asset Management Ab has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $766 Million distributed in 90 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $45.1M, Boston Scientific Corp with a value of $31.8M, Vertex Pharmaceuticals Inc with a value of $27.4M, Glaukos Corp with a value of $24.3M, and Intuitive Surgical Inc with a value of $24.1M.

Examining the 13F form we can see an decrease of $74.4M in the current position value, from $840M to 766M.

Rhenman & Partners Asset Management Ab is based out at Stockholm, V7

Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.

Portfolio value $766 Million
Healthcare: $766 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$722B
$45.1 Million 5.89% of portfolio
57,870
Q2 2025 Added 38.61%
$141B
$31.8 Million 4.15% of portfolio
296,000
Q2 2025 Reduced 1.33%
$99.4B
$27.4 Million 3.57% of portfolio
61,455
Q2 2025 Reduced 7.93%
$3.91B
$24.3 Million 3.17% of portfolio
235,000
Q2 2025 Reduced 12.96%
$153B
$24.1 Million 3.15% of portfolio
44,350
Q2 2025 Reduced 13.88%
$19.8B
$24 Million 3.14% of portfolio
136,429
Q2 2025 Added 7.68%
$140B
$24 Million 3.13% of portfolio
121,452
Q2 2025 Added 189.5%
$97.1B
$20.4 Million 2.66% of portfolio
295,362
Q2 2025 Added 25.23%
$99.5B
$20.3 Million 2.65% of portfolio
27,717
Q2 2025 Reduced 41.3%
$13.7B
$18.8 Million 2.45% of portfolio
149,217
Q2 2025 Added 66.13%
$141B
$18.6 Million 2.44% of portfolio
168,150
Q2 2025 Reduced 27.99%
$9.27B
$18.6 Million 2.43% of portfolio
350,000
Q2 2025 Reduced 20.45%
$3.12B
$18 Million 2.35% of portfolio
1,287,284
Q2 2025 Reduced 3.74%
$19.6B
$17.7 Million 2.31% of portfolio
175,435
Q2 2025 Reduced 5.43%
$74.4B
$17.4 Million 2.27% of portfolio
44,650
Q2 2025 Reduced 8.78%
$12.4B
$16.7 Million 2.18% of portfolio
136,400
Q2 2025 Added 264.71%
$126B
$15.6 Million 2.04% of portfolio
179,500
Q2 2025 Reduced 29.61%
$62.8B
$14.5 Million 1.9% of portfolio
27,700
Q2 2025 Reduced 12.76%
$22.4B
$14.5 Million 1.89% of portfolio
46,000
Q2 2025 Reduced 24.59%
$29.5B
$13.9 Million 1.82% of portfolio
159,500
Q2 2025 Added 2.9%
$390B
$12.9 Million 1.68% of portfolio
69,375
Q2 2025 Reduced 21.74%
$10.1B
$12.6 Million 1.64% of portfolio
66,500
Q2 2025 Added 60.24%
$15.6B
$12.4 Million 1.62% of portfolio
344,000
Q2 2025 Reduced 16.3%
$8.12B
$11.6 Million 1.51% of portfolio
109,030
Q2 2025 Reduced 12.28%
$115B
$11.4 Million 1.49% of portfolio
29,778
Q2 2025 Added 77.48%
$1.66B
$10.9 Million 1.43% of portfolio
190,000
Q2 2025 Reduced 57.59%
$90.5B
$10.6 Million 1.38% of portfolio
32,000
Q2 2025 Added 13.48%
$1.99B
$10.5 Million 1.38% of portfolio
197,600
Q2 2025 Added 113.62%
$6.48B
$10.1 Million 1.32% of portfolio
106,500
Q2 2025 Added 52.14%
$17B
$9.71 Million 1.27% of portfolio
57,500
Q2 2025 Reduced 58.48%
$5B
$9.48 Million 1.24% of portfolio
90,800
Q2 2025 Reduced 17.15%
$320B
$9.49 Million 1.24% of portfolio
30,430
Q2 2025 Reduced 60.7%
$39B
$9.24 Million 1.21% of portfolio
55,000
Q2 2025 New
$38.4B
$9.14 Million 1.19% of portfolio
49,375
Q2 2025 Added 52.51%
$10.1B
$8.23 Million 1.07% of portfolio
149,650
Q2 2025 Reduced 43.53%
$235B
$7.96 Million 1.04% of portfolio
58,500
Q2 2025 Added 12.5%
$8.68B
$7.19 Million 0.94% of portfolio
182,000
Q2 2025 Added 124.69%
$1.66B
$6.98 Million 0.91% of portfolio
190,000
Q2 2025 Added 26.67%
$3.32B
$6.69 Million 0.87% of portfolio
312,092
Q2 2025 Reduced 69.48%
$10.3B
$6.61 Million 0.86% of portfolio
22,200
Q2 2025 Reduced 67.45%
$3.12B
$6.1 Million 0.8% of portfolio
116,000
Q2 2025 Added 55.7%
$37.8B
$6 Million 0.78% of portfolio
68,000
Q2 2025 New
$1.21B
$5.6 Million 0.73% of portfolio
565,000
Q1 2025 Reduced 32.67%
$9.71B
$5.52 Million 0.72% of portfolio
21,500
Q2 2025 Added 877.27%
$18.1B
$5.41 Million 0.71% of portfolio
99,757
Q2 2025 Reduced 20.83%
$896M
$5.38 Million 0.7% of portfolio
574,000
Q2 2025 Added 32.56%
$4.76B
$5.08 Million 0.66% of portfolio
123,315
Q2 2025 Added 191.42%
$12.3B
$4.71 Million 0.62% of portfolio
26,000
Q2 2025 New
$185B
$4.52 Million 0.59% of portfolio
11,140
Q2 2025 Reduced 11.87%

Summary

  • Portfolio
  • No. of Stocks 90
  • Current Value $766 Million
  • Prior Value $840 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 11 stocks
  • Additional Purchases 29 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 37 stocks
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email